title: Episodic acyclovir therapy to abort recurrent attacks of genital herpes simplex infection.
abstract: Frequent recurrence of genital herpes simplex infection can be a distressing condition. Continuous suppressive oral acyclovir is effective but expensive. Hitherto episodic therapy has given disappointing results. An open comparative study of patient initiated therapy is reported here. Acyclovir 200 mg five times daily for five days aborted 44% of recurrences and shortened 38% by greater than or equal to 50%, giving useful response in 82% of 34 recurrences. Acyclovir 400 mg twice daily for five days aborted 60% and shortened 17% giving useful benefit in 77% of 20 recurrences. Acyclovir 200 mg twice a day for five days gave unsatisfactory results. Patients were selected for frequent recurrences and a recognized prodrome, and care was taken to help to identify early prodromal symptoms. In these patients acyclovir in dosages of 200 mg five times daily for five days and 400 mg bd for five days proved convenient and cost effective.
authors.affiliation: Department of Genitourinary Medicine, St. Thomas' Hospital, London, UK.
authors.forename: J D
authors.initials: JD
authors.lastname: Whatley
authors.forename: R N
authors.initials: RN
authors.lastname: Thin
mesh_terms: D000212:Acyclovir / Q000627:therapeutic use*; D000328:Adult; D005260:Female; D006558:Herpes Genitalis / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012074:Remission Induction; D013997:Time Factors
chemical_list: D000212:Acyclovir